Catalyst Pharmaceuticals
Price & Volume
Stats
See more52W Range | $19.05-$32.56 |
Market Cap | $3.8B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $596.9M |
Revenue Growth (YoY) | 5.6% |
Gross Profit (12 Mos) | $501.6M |
Diluted EPS | $1.73 |
News
See moreYahoo Finance • 4 days ago
Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus
Yahoo Finance • 5 days ago
This Biotech Stock Has Soared 175%. Here’s Why One Fund Still Sold $3 Million Worth
Yahoo Finance • 8 days ago
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
Yahoo Finance • 17 days ago
Sector Update: Health Care Stocks Softer in Afternoon Trading
About
CEO | Mr. Richard John Daly M.B.A. |
CFO | Mr. Michael W. Kalb CPA |
Address | 355 Alhambra Circle, Coral Gables, FL, United States, 33134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 182 |